New insights into Sjögren's disease pathogenesis and treatment

Autoantibodies News

New insights into Sjögren's disease pathogenesis and treatment
Autoimmune DiseaseBloodCalcium
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 81 sec. here
  • 24 min. at publisher
  • 📊 Quality Score:
  • News: 109%
  • Publisher: 71%

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine are closer to understanding what drives the autoimmune disorder Sjögren's disease, thanks to new discoveries about the role of calcium signaling, regulatory T cells, and interferon.

New York UniversityDec 18 2024 Research ers at NYU College of Dentistry and NYU Grossman School of Medicine are closer to understanding what drives the autoimmune disorder Sjögren's disease, thanks to new discoveries about the role of calcium signaling, regulatory T cells, and interferon.

Not being able to produce tears or saliva can have a great impact on one's life. If you can't produce saliva, it may hamper your speech and your ability to process food, increases your risk for developing cavities, and overall worsens one's health." In addition to low tear and saliva production, the hallmarks of Sjögren's disease-;and factors that help clinicians diagnose it-;are autoantibodies in the blood and lymphocytes in the salivary glands.

The calcium connection Lacruz and Feske study the role of calcium signaling in human diseases, including disorders of the immune system and those that affect the mouth. Calcium signaling is important for saliva production, but it is unclear to what extent it may be involved in the development of Sjögren's disease.

The role of regulatory T cells Previous studies revealed that genetically altering mice to lack calcium signaling in their immune system's T cells resulted in dysfunction in one particular type of T cell-;regulatory T cells-;which prompted inflammation and autoimmune disease in the mice. Regulatory T cells help control the immune system's response, but when they don't work as they should, they fail to prevent autoimmune disease.

Could a drug do the same? To test this idea, the researchers turned to an existing drug called baricitinib that is currently used to treat rheumatoid arthritis, alopecia, and more recently, hospitalized COVID-19 patients. Baricitinib is a JAK inhibitor that reduces inflammation by suppressing signals downstream of the interferon receptor.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Autoimmune Disease Blood Calcium Cell Cytokine Dentistry Fatigue Food Genes Immune System Inflammation Interferon Medicine Mouse Model Muscle Pain Pathology Research Rheumatology Salivary Gland Speech

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers develop new approach to effectively deliver therapeutics into the brainResearchers develop new approach to effectively deliver therapeutics into the brainResearchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach-;demonstrated in mouse models and isolated human brain tissue-;to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases.
Read more »

Researchers discover new cause of cytokine storm in COVID-19Researchers discover new cause of cytokine storm in COVID-19As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children's Hospital of Philadelphia, the University of Pittsburgh and Weill Cornell Medicine discovered a novel cause of cytokine storm -; the extreme inflammatory response associated with increased risk of death in COVID-19 infection.
Read more »

Researchers discover new pathway to forming long-term memories in the brainResearchers discover new pathway to forming long-term memories in the brainResearchers from Max Planck Florida Institute for Neuroscience have discovered a new pathway to forming long-term memories in the brain.
Read more »

Researchers discover new receptor in pain signaling pathwayResearchers discover new receptor in pain signaling pathwayResearchers at the NYU Pain Research Center have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a study published in the Journal of Clinical Investigation.
Read more »

Researchers gain new insights into the molecular changes leading to Rett syndromeResearchers gain new insights into the molecular changes leading to Rett syndromeResearchers at Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital and collaborating institutions have gained new insights into the molecular changes leading to Rett syndrome, a severe neurological disorder caused by mutations in the MeCP2 gene encoding methyl-CpG binding protein...
Read more »

The eating advice over calories that could help you live longerThe eating advice over calories that could help you live longerNew research conducted by American researchers has been published in Nature
Read more »



Render Time: 2025-02-12 09:09:06